Nakashima S, Take N, Hayashi H, Mazaki M
J Biochem. 1976 Jun;79(6):1323-30. doi: 10.1093/oxfordjournals.jbchem.a131186.
Mice primed with chemically modified bacterial alpha-amylase (BalphaA) [EC 3.2.1.1 alpha-amylase, B. subtilis], which was neither cross-reactive with anti-BalphaA antibody nor able to induce a humoral anti-BalphaA antibody response, developed enhanced responses to a subsequent challenge with native BalphaA (Nakashima et al. (1974) J. Biochem. 76, 349-357). The present studies were designed to examine the relationship of priming doses of BalphaA derivatives to the level of enhancement of the helper activity. Increasing the priming dose of modified antigens resulted in a greater degree of helper cell response until the maximal level of enhancement was reached. When injections for priming and challenge were given intraperitoneally, priming doses of D-BalphaA, M-BalphaA, and RM-BalphaA required for the maximal enhancement of helper activity were about 15, 50, and 15 mug, respectively. Further increase in the priming dose, conversely, resulted in suppressin of the enhanced helper activity, irrespective of whether the time interval between priming and challenge was 10 or 28 days. Suppression of the enhanced helper activity upon excessive dose priming with modified BalphaA derivatives was not specific for the anti-BalphaA antibody response. On the basis of these results it is suggested that this phenomenon of suppression might be partly accounted for by the regulatory mechanism functioning in antigenic competition.
用化学修饰的细菌α-淀粉酶(BalphaA)[EC 3.2.1.1α-淀粉酶,枯草芽孢杆菌]预致敏的小鼠,该酶既不与抗BalphaA抗体发生交叉反应,也不能诱导体液抗BalphaA抗体反应,对随后用天然BalphaA进行的攻击产生了增强的反应(中岛等人,(1974年)《生物化学杂志》76卷,349 - 357页)。本研究旨在检查BalphaA衍生物的预致敏剂量与辅助活性增强水平之间的关系。增加修饰抗原的预致敏剂量会导致辅助细胞反应增强程度更大,直到达到最大增强水平。当腹腔内给予预致敏和攻击注射时,辅助活性最大增强所需的D - BalphaA、M - BalphaA和RM - BalphaA的预致敏剂量分别约为15、50和15微克。相反,预致敏剂量的进一步增加会导致增强的辅助活性受到抑制,无论预致敏和攻击之间的时间间隔是10天还是28天。用修饰的BalphaA衍生物过量预致敏时对增强的辅助活性的抑制并非针对抗BalphaA抗体反应具有特异性。基于这些结果,提示这种抑制现象可能部分由抗原竞争中起作用的调节机制所解释。